Mciver; Edward Giles
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mciver; Edward Giles.The latest application filed is for "fused thiazolopyrimidine derivatives as mnks inhibitors".
- Mciver; Edward Giles - London GB
- McIver; Edward Giles - Sawbridgeworth GB
- McIver; Edward Giles - Bishops Stortford GB
| Patent | Date |
|---|---|
| Fused thiazolopyrimidine derivatives as MNKs inhibitors Grant 11,136,338 - Winter-Holt , et al. October 5, 2 | 2021-10-05 |
| Substituted tricyclic heterocyclic compounds and use thereof Grant 10,918,645 - Xia , et al. February 16, 2 | 2021-02-16 |
| Fused Thiazolopyrimidine Derivatives As MNKS Inhibitors App 20200247822 - Kind Code | 2020-08-06 |
| Fused thiazolopyrimidine derivatives as MNKS inhibitors Grant 10,669,284 - Winter-Holt , et al. | 2020-06-02 |
| Pyrropyrimidine compounds as MNKs inhibitors Grant 10,604,524 - Winter-Holt , et al. | 2020-03-31 |
| Substituted Tricyclic Heterocyclic Compounds And Use Thereof App 20190307763 - XIA; Yan ; et al. | 2019-10-10 |
| Fused Thiazolopyrimidine Derivatives As MNKS Inhibitors App 20180346483 - Winter-Holt; Jon James ; et al. | 2018-12-06 |
| Pyrropyrimidine Compounds As MNKS Inhibitors App 20180346469 - Winter-Holt; Jon James ; et al. | 2018-12-06 |
| Compounds App 20170320870 - MCIVER; Edward Giles ; et al. | 2017-11-09 |
| Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK Grant 8,569,281 - Chan , et al. October 29, 2 | 2013-10-29 |
| Pyrazolopyridines As Inhibitors Of The Kinase Lrrk2 App 20130267513 - Chan; Brayn ; et al. | 2013-10-10 |
| Compounds App 20120295883 - CHAN; Bryan K. ; et al. | 2012-11-22 |
| Tetrahydroindole derivatives for treatment of alzheimer's disease Grant 8,203,004 - Burkamp , et al. June 19, 2 | 2012-06-19 |
| Pyrrolopyrimidines And Used As Kinase Inhibitors App 20120088753 - Mciver; Edward Giles ; et al. | 2012-04-12 |
| Compounds App 20100317646 - Mciver; Edward Giles ; et al. | 2010-12-16 |
| Compound App 20100056524 - Mciver; Edward Giles ; et al. | 2010-03-04 |
| Amino-heterocycles as VR-1 antagonists for treating pain Grant 7,442,701 - Blurton , et al. October 28, 2 | 2008-10-28 |
| Sulphonamido-substituted bridged bicycloalkyl derivatives Grant 7,365,196 - Belanger , et al. April 29, 2 | 2008-04-29 |
| Substituted-1-phthalazinamines as vr-1 antagonists Grant 7,329,659 - Blurton , et al. February 12, 2 | 2008-02-12 |
| Amino-heterocycles as vr-1 antagonists for treating pain App 20060040947 - Blurton; Peter ; et al. | 2006-02-23 |
| Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain App 20050197342 - Hollingworth, Gregory John ; et al. | 2005-09-08 |
| Sulphonamido-substituted bridged bicycloalkyl derivatives App 20040029862 - Belanger, Patrice Charles ; et al. | 2004-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 